Teva Pharmaceutical Industries Limited

NYSE: TEVA · Real-Time Price · USD
16.20
0.58 (3.71%)
At close: May 02, 2025, 3:59 PM
16.20
-0.03%
After-hours: May 02, 2025, 05:43 PM EDT

Teva Pharmaceutical Industries Revenue

Teva Pharmaceutical Industries reported an annual revenue of $16.54B, reflecting a 4.4% growth. For the quarter ending December 31, 2024, Teva Pharmaceutical Industries generated $4.23B in revenue.
Revenue (ttm)
$16.54B
Revenue Growth
4.4%
Price / Sales Ratio
1.51
Revenue / Employee
$488.14K
Employees
33,892
Market Cap
18.57B

Revenue Chart

Created with Highcharts 11.4.316.66B16.66B15.88B15.88B14.93B14.93B15.85B15.85B16.54B16.54B2020202120222023202405B10B15B20B

Teva Pharmaceutical Industries Revenue - Annual

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 16.54B +4.40%
Dec 31, 2023 15.85B +6.17%
Dec 31, 2022 14.93B -6.00%
Dec 31, 2021 15.88B -4.68%
Dec 31, 2020 16.66B n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.